{"id":56268,"date":"2026-03-27T06:23:10","date_gmt":"2026-03-27T06:23:10","guid":{"rendered":"https:\/\/www.europesays.com\/be-fr\/56268\/"},"modified":"2026-03-27T06:23:10","modified_gmt":"2026-03-27T06:23:10","slug":"ce-que-change-la-prep-injectable","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/be-fr\/56268\/","title":{"rendered":"ce que change la PrEP injectable"},"content":{"rendered":"

\n Article premium,
\n R\u00e9serv\u00e9 aux\u00a0abonn\u00e9s\n <\/p>\n

La France est le premier pays europ\u00e9en \u00e0 rembourser un traitement pr\u00e9ventif du VIH\u00a0(PrEP) sous forme injectable. Autoris\u00e9 depuis fin f\u00e9vrier, les m\u00e9decins commencent tout juste \u00e0 le prescrire.<\/p>\n

\"La<\/p>\n

La PrEP\u00a0(prophylaxie pr\u00e9-exposition) par Cabot\u00e9gravir prend la forme d\u2019une injection intramusculaire \u00e0 r\u00e9aliser tous les deux mois, avec un soignant. | GETTY IMAGES<\/p>\n

fermer<\/p>\n

\"LaLa PrEP\u00a0(prophylaxie pr\u00e9-exposition) par Cabot\u00e9gravir prend la forme d\u2019une injection intramusculaire \u00e0 r\u00e9aliser tous les deux mois, avec un soignant. | GETTY IMAGES <\/p>\n

Publi\u00e9 le 27\/03\/2026 \u00e0 06h00<\/p>\n

Lire plus tard<\/p>\n

Partager<\/p>\n

FacebookFacebookBlueSkyBlueSkyFlipboardFlipboardlinkedinLinkedIn<\/p>\n

Newsletter M\u00e9decine et Sant\u00e9<\/p>\n

Chaque mercredi, une s\u00e9lection de contenus pour mieux comprendre l’actualit\u00e9 de la sant\u00e9<\/p>\n

Votre e-mail, avec votre consentement, est utilis\u00e9 par Ouest-France pour recevoir notre newsletter. En\u00a0savoir\u00a0plus<\/a>.<\/p>\n

On peut le prescrire depuis un peu plus d\u2019une semaine\u00a0\u00bb, s\u2019enthousiasme le Pr Jean-Michel Molina, infectiologue \u00e0 l\u2019h\u00f4pital Saint-Louis\u00a0(Paris), \u00e0 propos du Cabot\u00e9gravir<\/a> (Apr\u00e9tude), nouveau traitement pr\u00e9ventif du VIH\u00a0(qui permet d\u2019\u00e9viter l\u2019infection), rembours\u00e9 depuis le 2 mars<\/a>.<\/p>\n

Cette mol\u00e9cule, qui emp\u00eache la r\u00e9plication du virus, \u00e9tait d\u00e9j\u00e0 disponible en curatif pour traiter les personnes s\u00e9ropositives. Cette autorisation r\u00e9cente vient ajouter une seconde option de prophylaxie pr\u00e9-exposition\u00a0\u00a0(PrEP)<\/a>, cette fois sous la forme d\u2019une injection \u00e0 r\u00e9aliser tous les deux mois. <\/p>\n

Jusqu\u2019ici, les patients \u00e0 risque ne disposaient que d\u2019une seule mol\u00e9cule pour \u00e9viter la contamination\u00a0: le…<\/p>\n

Offre sans engagement<\/p>\n

\u00a0<\/p>\n

\u2713 L’acc\u00e8s \u00e0 tous les articles
\u2713 Le journal num\u00e9rique d\u00e8s 5h<\/p>\n

\u2713 Lecture sans publicit\u00e9<\/p>\n


\n Je m’abonne
\n<\/a><\/p>\n

ou<\/p>\n

Jusqu’\u00e0 -75% la premi\u00e8re ann\u00e9e<\/p>\n

\u00a0<\/p>\n

D\u00e9j\u00e0 abonn\u00e9 ? Connectez-vous<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Article premium, R\u00e9serv\u00e9 aux\u00a0abonn\u00e9s La France est le premier pays europ\u00e9en \u00e0 rembourser un traitement pr\u00e9ventif du VIH\u00a0(PrEP)…\n","protected":false},"author":2,"featured_media":56269,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[82],"tags":[12,13,18,17,86,467,828,87,10881,6798],"class_list":{"0":"post-56268","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sante","8":"tag-be","9":"tag-be-fr","10":"tag-belgique","11":"tag-belgium","12":"tag-health","13":"tag-maladies","14":"tag-medicaments","15":"tag-sante","16":"tag-sida","17":"tag-virus"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@be_fr\/116299707382666917","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/posts\/56268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/comments?post=56268"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/posts\/56268\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/media\/56269"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/media?parent=56268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/categories?post=56268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/tags?post=56268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}